SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA


KARABULUT M. , Afsar C. U. , KARABULUT S., PEKER K. D. , GEMICI E., Dagoglu N., ...Daha Fazla

ACTA MEDICA MEDITERRANEA, cilt.33, ss.613-619, 2017 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 33 Konu: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.19193/0393-6384_2017_4_091
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Sayfa Sayıları: ss.613-619

Özet

Background: Pancreatic adenocarcinoma (PA) is a very lethal malignancy. Different parameters have been found to be predictive and prognostic. This study was conducted to investigate the serum levels of interleukin-32 (IL-32) in patients with PA and the relationship with tumor progression and known prognostic parameters.